Low-modulus Mg/PCL hybrid bone substitute for osteoporotic fracture fixation

Biomaterials

Volumn 34, Issue 29, 2013, Pages 7016-7032

  Wong, Hoi Man ^a   Wu, Shuilin ^b   Chu, Paul K ^b   Cheng, Shuk Han ^b   Luk, Keith D K ^a   Cheung, Kenneth M C ^a   Yeung, Kelvin W K ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

Author keywords

Bioactive; Biodegradable; Low modulus; Magnesium; Polycaprolactone

Indexed keywords

ELASTIC MODULI; FRACTURE FIXATION; MAGNESIUM; MECHANICAL PROPERTIES; POLYCAPROLACTONE;

BIOACTIVE; BIODEGRADABLE; BIODEGRADABLE COMPOSITES; BULK MECHANICAL PROPERTIES; LOW MODULUS; OSTEOBLASTIC DIFFERENTIATION; OSTEOPOROTIC FRACTURES; SIMULATED BODY FLUIDS;

BONE;

CALCIUM; MAGNESIUM; PHOSPHATE; POLY(METHYL METHACRYLATE); POLYCAPROLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE PROSTHESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DEGRADATION; FRACTURE FIXATION; FRAGILITY FRACTURE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 84879604606     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.062     Document Type: Article

References (59)

1. Barrette-Connor E. The economic and human costs of osteoporotic fracture. Am J Med 1995, 98:3S-8S.
2. Iqbal M.M. Osteoporosis: epidemiology, diagnosis, and treatment. South Med J 2000, 93:2-18.
3. Cornell C.N. Internal fracture fixation in patients with osteoporosis. JAm Acad Orthop Surg 2003, 11(2):109-119.
4. Dennison E., Cooper C. Epidemiology of osteoporotic fractures. Horm Res 2000, 54:58-63.
5. Charnley J. Anchorage of the femoral head prosthesis to the shaft of the femur. JBone Joint Surg Am 1960, 42B:28-30.
6. Hernandez L., Gurruchaga M., Goni I. Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Formulation and rheological behaviour. JMater Sci Mater Med 2008, 20:89-97.
7. Belkoff S.M., Molloy S. Temperature measurement during polymerization of polymethylmethacrylate cement used for vertebroplasty. Spine 2003, 28(14):1555-1559.
8. Grados F., Depriester C., Cayrolle G., Hardy N., Deramond H., Fardellone P. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology 2000, 39(12):1410-1414.
9. Piazzolla A., De Giorgi G., Solarino G. Vertebral body recollapse without trauma after kyphoplasty with calcium phosphate cement. Musculoskelet Surg 2011, 95:141-145.
10. Larsson S. Cement augmentation in fracture treatment. Scand J Surg 2006, 95:111-118.
11. Ahn D.K., Choi D.J., Lee S. Spinal cord injury caused by bone cement after percutaneous vertebroplasty: one case of long-term follow-up and the result of delayed removal. JKorean Orthop Assoc 2009, 44:386-390.
12. Bai B., Jazrawi L.M., Kummer F.J., Spivak J.M. The use of an injectable, biodegradable calcium phosphate bone substitute for the prophylactic augmentation of osteoporotic vertebrae and the management of vertebral compression fractures. Spine 1999, 24(15):1521-1526.
13. Lim T.H., Brebach G.T., Renner S.M., Kim W.J., Kim J.G., Lee R.E., et al. Biomechanical evaluation of an injectable calcium phosphate cement for vertebroplasty. Spine 2002, 27(12):1297-1302.
14. Boger A., Heini P., Windolf M., Schneider E. Adjacent vertebral failure after vertebroplasty: a biomedical study of low-modulus PMMA cement. Eur Spine J 2007, 16:2118-2125.
15. Boger A., Bohner M., Heini P., Schwieger K., Schneider E. Performance of vertebral cancellous bone augmented with compliant PMMA under dynamic loads. Acta Biomater 2008, 4:1688-1693.
16. Arens D., Rothstock S., Windolf M., Boger A. Bone marrow modified acrylic bone cement for augmentation of osteoporotic cancellous bone. JMech Behav Biomed Mater 2011, 4(8):2081-2089.
17. Lopez-Heredia M.A., Sa Y., Salmon P., de Wijn J.R., Wolke J.G.C., Jansen J.A. Bulk properties and bioactivity assessment of porous polymethylmethacrylate cement loaded with calcium phosphates under simulated physiological conditions. Acta Biomater 2012, 8(8):3120-3127.
18. Larsson S., Bauer T.W. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin Orthop Relat Res 2002, 395:23-32.
19. Castaldini A., Cavallini A. Setting properties of bone cement with added synthetic hydroxyapatite. Biomaterials 1985, 6(1):55-60.
20. Heini P.F., Berlemann U. Bone substitutes in vertebroplasty. Eur Spine J 2001, 10:S205-S213.
21. Wang Y.B., Xie X.H., Li H.F., Wang X.L., Zhao M.Z., Zhang E.W., et al. Biodegradable CaMgZn bulk metallic glass for potential skeletal application. Acta Biomater 2011, 7(8):3196-3208.
22. Xue Z.L., Zhang H., Jin A.M., Ye J.D., Ren L., Ao J., et al. Correlation between degradation and compressive strength of an injectable macroporous calcium phosphate cement. JAlloys Compd 2012, 520:220-225.
23. Gu T., Shi H.S., Ye J.D. Reinforcement of calcium phosphate cement by incorporating with high-strength beta-tricalcium phosphate aggregates. JBiomed Mater Res B Appl Biomater 2012, 100B(2):350-359.
24. Puppi D., Chiellini F., Piras A.M., Chiellini E. Polymeric materials for bone and cartilage repair. Prog Polym Sci 2010, 35(4):403-440.
25. Rodenas-Rochina J., Ribelles J.L., Lebourg M. Comparative study of PCL-HAp and PCL-bioglass composite scaffolds for bone tissue engineering. JMater Sci Mater Med 2013, 24(5):1293-1308.
26. Hutmacher D.W., Woodruff M.A. The return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci 2010, 35(10):1217-1256.
27. Krupa I., Cecen V., Boudenne A., Prokeš J., Novák I. The mechanical and adhesive properties of electrically and thermally conductive polymeric composites based on high density polyethylene filled with nickel powder. Mater Des 2013, 51:620-628.
28. Al-Abdullat Y., Tsutsumi S., Nakajima N., Ohta M., Kuwahara H., Ikeuchi K. Surface modification of magnesium by NaHCO(3) and corrosion behavior in Hank's solution for new biomaterial applications. Mater Trans 2001, 42(8):1777-1780.
29. Witte F. The history of biodegradable magnesium implants: a review. Acta Biomater 2010, 6(5):1680-1692.
30. Song G. Control of biodegradation of biocompatable magnesium alloys. Corros Sci 2007, 49(4):1696-1701.
31. Boccaccini A.R., Hoppe A., Guldal N.S. Areview of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011, 32(11):2757-2774.
32. Dhert W.J.A., van Gaalen S.M., Kruyt M.C., Geuze R.E., de Bruijn J.D., Alblas J. Use of fluorochrome labels in invivo bone tissue engineering research. Tissue Eng Part B Rev 2010, 16(2):209-217.
33. Habibovic P., Kruyt M.C., Juhl M.V., Clyens S., Martinetti R., Dolcini L., et al. Comparative invivo study of six hydroxyapatite-based bone graft substitutes. JOrthop Res 2008, 26(10):1363-1370.
34. Rahn B.A., Perren S.M. Xylenol orange, a fluorochrome useful in polychrome sequential labeling of calcifying tissues. Stain Technol 1971, 46(3):125-129.
35. Peake B.M., Ashoka S., Bremner G., Hageman K.J., Reid M.R. Comparison of digestion methods for ICP-MS determination of trace elements in fish tissues. Anal Chim Acta 2009, 653(2):191-199.
36. Cubadda F., Raggi A., Coni E. Element fingerprinting of marine organisms by dynamic reaction cell inductively coupled plasma mass spectrometry. Anal Bioanal Chem 2006, 384(4):887-896.
37. Erben R.G. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. JHistochem Cytochem 1997, 45(2):307-313.
38. Banse X., Sims T.J., Bailey A.J. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. JBone Miner Res 2002, 17(9):1621-1628.
39. Zreiqat H., Howlett C.R., Zannettino A., Evans P., Tanzil G.S., Knabe C., et al. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. JBiomed Mater Res 2002, 62(2):175-184.
40. Li L., Gao J., Wang Y. Evaluation of cyto-toxicity and corrosion behavior of alkali-heat-treated magnesium in simulated body fluid. Surf Coat Technol 2004, 185(1):92-98.
41. Rude R.K., Gruber H.E., Norton H.J., Wei L.Y., Frausto A., Mills B.G. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. JNutr 2004, 134(1):79-85.
42. Rude R.K., Gruber H.E., Norton H.J., Wei L.Y., Frausto A., Kilburn J. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. Bone 2005, 37(2):211-219.
43. Toba Y., Kajita Y., Masuyama R., Takada Y., Suzuki K., Aoe S. Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. JNutr 2000, 130(2):216-220.
44. Matinlinna J.P., Areva S., Lassila L.V.J., Vallittu P.K. Characterization of siloxane films on titanium substrate derived from these aminosilanes. Surf Interface Anal 2004, 36:1314-1322.
45. 2 nano-particles with silane coupling agent and investigation of its effect on the properties of polyurethane composite coating. Prog Org Coat 2009, 65:222-228.
46. Lin J., Siddiqui J.A., Ottenbrite R.M. Surface modification of inorganic oxide particles with silane coupling agent and organic dyes. Polym Adv Technol 2001, 12(5):285-292.
47. Wang T.X., Chow L.C., Frukhtbeyn S.A., Ting A.H., Dong Q.X., Yang M.S., et al. Improve the strength of PLA/HA composite through the use of surface initiated polymerization and phosphonic acid coupling agent. JRes Natl Inst Stand Technol 2011, 116(5):785-796.
48. Shen Y.H., Liu W.C., Lin K.L., Pan H.B., Darvell B.W., Peng S.L., et al. Interfacial pH: a critical factor for osteoporotic bone regeneration. Langmuir 2011, 27(6):2701-2708.
49. Kuwahara H., Al-Abdullat Y., Mazaki N., Tsutsumi S., Aizawa T. Precipitation of magnesium apatite on pure magnesium surface during immersing in Hank's solution. Mater Trans 2001, 42(7):1317-1321.
50. Zhang E.L., Yang L. Biocorrosion behavior of magnesium alloy in different simulated fluids for biomedical application. Mat Sci Eng C-Bio S 2009, 29(5):1691-1696.
51. Zhang E.L., Xu L.P., Yu G.N., Pan F., Yang K. Invivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation. JBiomed Mater Res A 2009, 90A(3):882-893.
52. Dupraz A.M.P., vandenMeer S.A.T., DeWijn J.R., Goedemoed J.H. Biocompatibility screening of silane-treated hydroxyapatite powders, for use as filler in resorbable composites. JMater Sci Mater Med 1996, 7(12):731-738.
53. Hussain A., Bessho K., Takahashi K., Tabata Y. Magnesium calcium phosphate as a novel component enhances mechanical/physical properties of gelatin scaffold and osteogenic differentiation of bone marrow mesenchymal stem cells. Tissue Eng Part A 2012, 18(7-8):768-774.
54. Witte F., Kaese V., Haferkamp H., Switzer E., Meyer-Lindenberg A., Wirth C.J., et al. Invivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005, 26(17):3557-3563.
55. Li Z., Gu X., Lou S., Zheng Y. The development of binary Mg-Ca alloys for use as biodegradable materials within bone. Biomaterials 2008, 29(10):1329-1344.
56. Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med 2003, 24:27-37.
57. Xu L., Yu G., Zhang E., Pan F., Yang K. Invivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application. JBiomed Mater Res A 2007, 83A(3):703-711.
58. Berlemann U., Ferguson S.J., Nolte L.P., Heini P.F. Adjacent vertebral failure after vertebroplasty. JBone Joint Surg Br 2002, 84:748-752.
59. Frankel B.M., Monroe T., Wang C. Percutaneous vertebral augmentation: an elevation in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty. Spine J 2007, 7:575-582.